Latest News Releases From The Newsroom
Pfizer, OPKO Health: FDA OKs GHD Treatment; Eton Pharma Faces Regulatory Setbacks
June 28th, 2023
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (Nasdaq: OPK) said that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a once-weekly treatment for pediatric patients with growth hormone deficiency (G. Read more
President Biden's Economic Vision Pays Off: The Rise of Bidenomics
June 28th, 2023
Bidenomics, the economic vision of President Biden, has proven to be successful in growing the economy from the middle out and bottom up, rather than relying on a top-down approach. The strategy was implemented to address longstanding challenges in t. Read more
Theriva Soars On VCN-01's FDA-Status, AST SpaceMobile Plunges On Equity Offering
June 28th, 2023
Theriva Biologics, Inc. (NYSE American: TOVX) made a significant announcement as the U.S. FDA granted orphan drug designation to VCN-01, the company's innovative oncolytic adenovirus, for treating pancreatic cancer. VCN-01 is designed to selective. Read more
Upside Prospects: META, DNN, ROP, SPOT, GWRE, PPTA, ESMT - Key Buy Ratings
June 27th, 2023
Meta Platforms, Inc. (Nasdaq: META), a prominent social media and technology company, was maintained with a Buy rating by Citigroup, who raised the price target from $315 to $360. Despite $META closing at $287.05 on Tuesday, the revised pric. Read more
Breaking: AeroVironment, Transphorm, and Tesla - Market Movers
June 27th, 2023
AeroVironment, Inc. (Nasdaq: AVAV) reported fourth-quarter fiscal 2023 adjusted EPS of $0.99, slightly below the consensus estimate of $1.01. Looking ahead to the full-year fiscal 2024, the company anticipates revenue ranging between $630 million . Read more
US Govt's Advisory On Sub-Saharan Africa's Gold Sector: Opportunities & Risks
June 27th, 2023
The U.S. Department of State, the U.S. Department of the Treasury, the U.S. Department of Commerce, the U.S. Department of Homeland Security, the U.S. Department of Labor, and the United States Agency for International Development issued a business r. Read more
Market Turmoil: Regeneron Takes a Hit After FDA's CRL
June 27th, 2023
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) tumbled more than 8% during intraday trading in response to the company receiving a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). The CRL was issued for th. Read more
Market Surge: Black Diamond Therapeutics' Clinical Breakthrough, Centogene's Deal with Lifera
June 27th, 2023
Shares of Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) soared over 100% in pre-market trading following the release of initial clinical data for BDTX-1535. The investigational drug, a fourth-generation epidermal growth factor receptor (EGFR) Maste. Read more
Earnings: Walgreens and TD SYNNEX Fall Short, Korn Ferry In-Line
June 27th, 2023
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) posted third-quarter fiscal 2023 adjusted earnings per share (EPS) of $1.00, falling short of the consensus estimate of $1.07. For the full fiscal year 2023, the company revised its adjusted EPS guidanc. Read more
Takeover Proposal Boosts American Equity, Delta Air Lines Boosts FY23 Outlook
June 27th, 2023
Shares of American Equity Investment Life Holding Company (NYSE: AEL) experienced a significant surge in premarket trading, rising over 10%. The boost came after the company confirmed receiving a takeover proposal from Brookfield Reinsurance Ltd. (NY. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login